Laura Schanberg is a Durham, North Carolina based female rheumatologist who is specialized in Rheumatology. Active license number of Laura Schanberg for Rheumatology is 31417 in North Carolina. Laura Schanberg treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Laura Schanberg speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
M.D.
Gender:
Female
Practice Address:
2100 Erwin Rd, Durham, North Carolina, 27710-0001
Phone:
919-620-4467
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1558424333
NPI Enumeration Date:
19 Dec, 2006
NPI Last Update On:
06 Jun, 2012
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Laura Schanberg are as mentioned below.
License Number
Specialization
State
Status
31417
Rheumatologist
North Carolina
Primary
31417
Pediatrics
North Carolina
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2100 Erwin Rd, Duke University Medical Center - Dumc 3212 Durham, North Carolina
Zip:
27710-0001
Phone Number:
--
Fax Number:
--
Patients can reach Laura Schanberg at 2100 Erwin Rd, Durham, North Carolina or can call to book an appointment on 919-620-4467. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.